百應控股(08525.HK):委員會決定維持上市科暫停股份買賣的決定
格隆匯10月26日丨百應控股(08525.HK)發佈公吿,聯交所GEM上市委員會已於2023年9月26日就上市科決定舉行復核聆訊。2023年10月25日,公司接獲聯交所的函件,通知公司,經考慮公司及上市科提交的所有書面及口頭呈件後,委員會認為公司未能維持GEM上市規則第17.26條所規定的確保公司股份繼續上市所需的足夠營運及資產水平,並決定維持上市科按GEM上市規則第9.04(3)條做出的有關暫停股份買賣的決定(“GLC決定”)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.